Earnings Call · Q2 FY2024·2024-08-08

Q2 24EPS -9.30%·Rev n/aQ1 24EPS -14.81%·Rev n/aQ4 23EPS -4.65%·Rev n/aQ3 23EPS -14.77%·Rev n/a⚠ consensus missing

Crinetics Pharmaceuticals, Inc. CRNX

Gayathri Diwakar — Host/Investor Relations

Scott Struthers — Founder and Chief Executive Officer

Dana Pizzuti — Chief Medical and Development Officer

Jim Hassard — Chief Commercial Officer

Marc Wilson — Chief Financial Officer

−6.1%1d on move date−6.6% vs SPY3d−0.8%5d+3.5%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CRNX calls or request research access.

More CRNX calls Browse calls Request research access